HRQoL in Hair Loss-Affected Patients with Alopecia Areata, Androgenetic Alopecia, and Telogen Effluvium: The Role of Personality Traits and Psychosocial Anxiety

    Paolo Russo, Edita Fino, Chiara Mancini, Mazzetti M, Michela Starace, Bianca Maria Piraccini
    Image of study
    TLDR Personality traits and anxiety affect hair loss patients' quality of life.
    The study aimed to investigate the impact of personality traits and psychosocial anxiety on the health-related quality of life (HRQoL) of patients with alopecia areata, androgenetic alopecia, and telogen effluvium. The study involved 143 patients who completed questionnaires assessing their HRQoL, personality traits, and psychosocial anxiety. The results showed that personality traits and psychosocial anxiety were significant predictors of HRQoL in these patients. The study highlights the importance of considering psychological factors in the management of hair loss-affected patients.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

      community My scalp punch biopsy results🤔?

      in Female  8 upvotes 1 year ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

      community AGA evaluation and first steps - BEGINNER MEGAPOST

      in Chat  75 upvotes 2 months ago
      The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    2 / 2 results